• Text size
  • Send this article to a friend
  • Print this article

Syntropharma raises £1.25m to push drug patch

Borders pharmaceutical firm Syntropharma has raised £1.25m from investors as it attempts to bring its revamped depression drug to market.

Custom byline text: 
TIM SHARP

Borders pharmaceutical firm Syntropharma has raised £1.25m from investors as it attempts to bring its revamped depression drug to market.